Covidien touts 510(k) win for Nellcor respiration rate software

March 20, 2012 by MassDevice staff

Covidien plans a limited release of its Nellcor respiration rate system following its FDA 510(k) win.

Covidien's Nellcor

Covidien (NYSE:COV) landed an FDA win for its Nellcor respiration system with version 1.0 software and adult respiratory sensor.

The Mansfield, Mass.-based med-tech titan is preparing a limited market release in the U.S. next month, allowing select hospitals to use the Nellcor system, according to a press release.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp